changing from tirzepatide to semaglutide Switching between weight-loss medications Switching GLP-1 Agonists for MAXIMUM

The odds ratio for vomiting with cagrilintide versus semaglutide or liraglutide was 0.38, meaning cagrilintide caused vomiting at roughly one-third the rate

Because the bioavailability of 7,8-DHF given by IP injection is unknown, the PK parameters from our model are interpreted as apparent parameters, which may be different if the drug is given by a different route

GLP-1 Receptor Agonists in Diabetic Kidney Disease: from Clinical Outcomes to Mechanisms

Eli Lilly is also developing orforglipron, an oral GLP-1 pill, in parallel, so the company is effectively pursuing the next generation of obesity care across both injectable and pill formats